These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 25564616)

  • 1. Rictor/mTORC2 pathway in oocytes regulates folliculogenesis, and its inactivation causes premature ovarian failure.
    Chen Z; Kang X; Wang L; Dong H; Wang C; Xiong Z; Zhao W; Jia C; Lin J; Zhang W; Yuan W; Zhong M; Du H; Bai X
    J Biol Chem; 2015 Mar; 290(10):6387-96. PubMed ID: 25564616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Rictor/mTORC2 in cardiomyocyte differentiation of mouse embryonic stem cells
    Zheng B; Wang J; Tang L; Tan C; Zhao Z; Xiao Y; Ge R; Zhu D
    Int J Biol Sci; 2017; 13(1):110-121. PubMed ID: 28123351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rictor, an mTORC2 Protein, Regulates Murine Lymphatic Valve Formation Through the AKT-FOXO1 Signaling.
    Banerjee R; Knauer LA; Iyer D; Barlow SE; Shalaby H; Dehghan R; Scallan JP; Yang Y
    Arterioscler Thromb Vasc Biol; 2024 Sep; 44(9):2004-2023. PubMed ID: 39087350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex.
    Carson RP; Fu C; Winzenburger P; Ess KC
    Hum Mol Genet; 2013 Jan; 22(1):140-52. PubMed ID: 23049074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan.
    Lamming DW; Mihaylova MM; Katajisto P; Baar EL; Yilmaz OH; Hutchins A; Gultekin Y; Gaither R; Sabatini DM
    Aging Cell; 2014 Oct; 13(5):911-7. PubMed ID: 25059582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional astroglial Rictor overexpression induces malignant glioma in mice.
    Bashir T; Cloninger C; Artinian N; Anderson L; Bernath A; Holmes B; Benavides-Serrato A; Sabha N; Nishimura RN; Guha A; Gera J
    PLoS One; 2012; 7(10):e47741. PubMed ID: 23077666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTORC1 Signaling in oocytes is dispensable for the survival of primordial follicles and for female fertility.
    Gorre N; Adhikari D; Lindkvist R; Brännström M; Liu K; Shen Y
    PLoS One; 2014; 9(10):e110491. PubMed ID: 25338086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
    Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
    Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors.
    Lee D; Sykes SM; Kalaitzidis D; Lane AA; Kfoury Y; Raaijmakers MH; Wang YH; Armstrong SA; Scadden DT
    Stem Cell Reports; 2014 Nov; 3(5):832-40. PubMed ID: 25418727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
    Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
    J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
    Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
    Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage.
    Völkers M; Konstandin MH; Doroudgar S; Toko H; Quijada P; Din S; Joyo A; Ornelas L; Samse K; Thuerauf DJ; Gude N; Glembotski CC; Sussman MA
    Circulation; 2013 Nov; 128(19):2132-44. PubMed ID: 24008870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.
    Artinian N; Cloninger C; Holmes B; Benavides-Serrato A; Bashir T; Gera J
    J Biol Chem; 2015 Aug; 290(32):19387-401. PubMed ID: 25998128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the in vivo safety profiles of Rictor inhibition using a zebrafish model.
    Cao Y; Jiang L; Zhao L; Zhou X; Wang N; Zhang P; Tang Y; Zhou J
    Curr Pharm Des; 2015; 21(12):1645-53. PubMed ID: 25557637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC2 is required for proliferation and survival of TSC2-null cells.
    Goncharova EA; Goncharov DA; Li H; Pimtong W; Lu S; Khavin I; Krymskaya VP
    Mol Cell Biol; 2011 Jun; 31(12):2484-98. PubMed ID: 21482669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of beta subunit of protein kinase CK2 in mouse oocytes causes follicle atresia and premature ovarian failure.
    Liang QX; Wang ZB; Lin F; Zhang CH; Sun HM; Zhou L; Zhou Q; Schatten H; Odile FC; Brigitte B; Sun QY; Qian WP
    Cell Death Dis; 2018 May; 9(5):508. PubMed ID: 29725001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-specific Rictor deletion induces M1 macrophage polarization and potentiates in vivo pro-inflammatory response to lipopolysaccharide.
    Festuccia WT; Pouliot P; Bakan I; Sabatini DM; Laplante M
    PLoS One; 2014; 9(4):e95432. PubMed ID: 24740015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2.
    Boulbes D; Chen CH; Shaikenov T; Agarwal NK; Peterson TR; Addona TA; Keshishian H; Carr SA; Magnuson MA; Sabatini DM; Sarbassov dos D
    Mol Cancer Res; 2010 Jun; 8(6):896-906. PubMed ID: 20501647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IKK interacts with rictor and regulates mTORC2.
    Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M
    Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.
    Morrison Joly M; Hicks DJ; Jones B; Sanchez V; Estrada MV; Young C; Williams M; Rexer BN; Sarbassov dos D; Muller WJ; Brantley-Sieders D; Cook RS
    Cancer Res; 2016 Aug; 76(16):4752-64. PubMed ID: 27197158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.